Updated By: LatestGKGS Desk
Chikungunya fever vaccine derived from Eilat virus
Researchers develop Vacine for Chikungunya fever from insect sepecific Eilat virus
Researchers from United States have developed a Vaccine for Chikungunya fever made from the insect-specific Eilat virus.
This is the first Chikungunya vaccine discovered by the researchers which does not have any side effects and is safe and effective for the humans.
Single dose of Chikungunya vaccine can prodice neutralising antibodies which lasts more than 290 days
The research show that it quickly produces a strong immune system which protects the patients from disease exposed to Chikungunya virus.
The vaccine trials show that there was neither evidence of virus in the blood nor signs of illness such as fever after Chikungunya virus infection in primates.
The Chikungunya vaccine was found structurally identical to natural chikungunya virus and its single dose can produce neutralising antibodies which lasted more than 290 days.
